Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful achievement of sustained virological response to triple combination therapy containing simeprevir in two patients with chronic hepatitis C who had failed asunaprevir:Daclatasvir combination therapy.
Ozeki I, Nakajima T, Yamaguchi M, Kimura M, Arakawa T, Kuwata Y, Ohmura T, Sato T, Hige S, Karino Y, Toyota J. Ozeki I, et al. Among authors: toyota j. Hepatol Res. 2016 Oct;46(11):1162-1167. doi: 10.1111/hepr.12667. Epub 2016 May 2. Hepatol Res. 2016. PMID: 26857426
Analysis of hepatitis B surface antigen (HBsAg) using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays.
Ozeki I, Nakajima T, Suii H, Tatsumi R, Yamaguchi M, Kimura M, Arakawa T, Kuwata Y, Ohmura T, Hige S, Karino Y, Toyota J. Ozeki I, et al. Among authors: toyota j. Hepatol Res. 2018 Feb;48(3):E263-E274. doi: 10.1111/hepr.12979. Epub 2017 Oct 26. Hepatol Res. 2018. PMID: 28884879
Zinc deficiency in patients with chronic liver disease in Japan.
Ozeki I, Arakawa T, Suii H, Tatsumi R, Yamaguchi M, Nakajima T, Kuwata Y, Toyota J. Ozeki I, et al. Among authors: toyota j. Hepatol Res. 2020 Mar;50(3):396-401. doi: 10.1111/hepr.13465. Epub 2020 Jan 16. Hepatol Res. 2020. PMID: 31783432 Free PMC article.
Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients.
Kumada H, Suzuki F, Suzuki Y, Toyota J, Karino Y, Chayama K, Kawakami Y, Fujiyama S, Ito T, Itoh Y, Tamura E, Ueki T, Ishikawa H, Hu W, McPhee F, Linaberry M, Hughes E. Kumada H, et al. Among authors: toyota j. J Gastroenterol Hepatol. 2016 Jan;31(1):14-22. doi: 10.1111/jgh.13073. J Gastroenterol Hepatol. 2016. PMID: 26252875 Clinical Trial.
113 results